Univariate analysis of prognostic factors in patients with nasal NK/T-cell lymphoma
Prognostic factor . | No. of patients . | Estimated OS 5-y rate, % . | P . | Estimated EFS 5-y rate, % . | P . |
---|---|---|---|---|---|
Expression of P19* | .009 | .02 | |||
Positive, more than 10% of tumor cells | 26 | 64 ± 9† | 61 ± 10† | ||
Negative 10% or less of tumor cells | 13 | 23 ± 11† | 23 ± 12† | ||
Apoptotic index* | .05 | .08 | |||
Low, 10 or fewer cells/hpf | 25 | 36 ± 10† | 32 ± 10† | ||
High, more than 10 cells/hpf | 12 | 67 ± 14† | 58 ± 14† | ||
IPI score | .06 | .2 | |||
Lower than 2 | 31 | 59 ± 9† | 47 | ||
Higher than 2 | 17 | 29 ± 11† | 29 | ||
Histology | .4 | .3 | |||
Small/medium cells | 22 | 43 | 39 | ||
Medium/large cells | 26 | 53 | 49 | ||
Expression of aC3* | .8 | .7 | |||
Low, fewer than 10 tumor cells | 23 | 43 | 39 | ||
High, 10 or more tumor cells | 13 | 46 | 38 |
Prognostic factor . | No. of patients . | Estimated OS 5-y rate, % . | P . | Estimated EFS 5-y rate, % . | P . |
---|---|---|---|---|---|
Expression of P19* | .009 | .02 | |||
Positive, more than 10% of tumor cells | 26 | 64 ± 9† | 61 ± 10† | ||
Negative 10% or less of tumor cells | 13 | 23 ± 11† | 23 ± 12† | ||
Apoptotic index* | .05 | .08 | |||
Low, 10 or fewer cells/hpf | 25 | 36 ± 10† | 32 ± 10† | ||
High, more than 10 cells/hpf | 12 | 67 ± 14† | 58 ± 14† | ||
IPI score | .06 | .2 | |||
Lower than 2 | 31 | 59 ± 9† | 47 | ||
Higher than 2 | 17 | 29 ± 11† | 29 | ||
Histology | .4 | .3 | |||
Small/medium cells | 22 | 43 | 39 | ||
Medium/large cells | 26 | 53 | 49 | ||
Expression of aC3* | .8 | .7 | |||
Low, fewer than 10 tumor cells | 23 | 43 | 39 | ||
High, 10 or more tumor cells | 13 | 46 | 38 |